Healthcare communications firm Spok's Q3 revenue falls 2.9%, reaffirms 2025 guidance

Reuters
Oct 30, 2025
Healthcare communications firm Spok's Q3 revenue falls 2.9%, reaffirms 2025 guidance

Overview

  • Spok Q3 2025 total revenue declines 2.9% yr/yr

  • Wireless ARPU rises 3% yr/yr, net churn improves by 20 bps

  • Company returns $6.4 mln in capital to stockholders in Q3 2025

Outlook

  • Spok reaffirms 2025 revenue guidance of $138.0 mln to $143.5 mln

  • Company expects 2025 adjusted EBITDA between $28.5 mln and $32.5 mln

  • Spok projects 2025 wireless revenue between $71.5 mln and $73.5 mln

Result Drivers

  • MANAGED SERVICES REVENUE - Growth in managed services revenue contributed to stable software revenue despite declines in other areas

  • WIRELESS ARPU - Wireless average revenue per unit increased by 3% year-over-year, supporting revenue stability

  • R&D INVESTMENT - Spok invested $9.1 mln in R&D to support future growth in its product platform

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Net Income

$3.20 mln

Q3 Adjusted EBITDA

$6.61 mln

Q3 Adjusted Operating Expenses

$28.48 mln

Q3 Operating Expenses

$29.51 mln

Q3 Software Revenue

$16.07 mln

Analyst Coverage

  • The one available analyst rating on the shares is "buy"

  • The average consensus recommendation for the wireless telecommunications services peer group is "buy"

  • Wall Street's median 12-month price target for Spok Holdings Inc is $19.50, about 15.8% above its October 28 closing price of $16.41

  • The stock recently traded at 20 times the next 12-month earnings vs. a P/E of 22 three months ago

Press Release: ID:nBw7j0d03a

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10